01 1Curia
01 1VILOXAZINE HYDROCHLORIDE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-05-21
Pay. Date : 2024-05-10
DMF Number : 39826
Submission : 2024-04-12
Status : Active
Type : II
20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is VILOXAZINE HYDROCHLORIDE, with a corresponding US DMF Number 39826.
Remarkably, this DMF maintains an Active status since its submission on April 12, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 21, 2024, and payment made on May 10, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
